doi: 10.1016/j.medcli.2012.04.021.
Epub 2012 Jun 27.
[Disease modifying drugs in multiple sclerosis and pregnancy]
[Article in
Spanish]
Affiliations
- PMID: 22743277
- DOI: 10.1016/j.medcli.2012.04.021
Item in Clipboard
[Disease modifying drugs in multiple sclerosis and pregnancy]
[Article in
Spanish]
Med Clin (Barc).
.
No abstract available
Similar articles
-
[Multiple sclerosis and pregnancy].Duodecim. 2013;129(14):1457-64. Duodecim. 2013. PMID: 23961604 Review. Finnish.
-
Balancing the benefits and risks of disease-modifying therapy in patients with multiple sclerosis.J Neurol Sci. 2011 Dec;311 Suppl 1:S29-34. doi: 10.1016/S0022-510X(11)70006-5. J Neurol Sci. 2011. PMID: 22206763
-
Fingolimod and multiple sclerosis: four cautionary tales.Neurology. 2012 Nov 6;79(19):1942-3. doi: 10.1212/WNL.0b013e3182735edf. Epub 2012 Oct 3. Neurology. 2012. PMID: 23035058 No abstract available.
-
Disease-modifying drugs for multiple sclerosis in pregnancy: a systematic review.Neurology. 2012 Sep 11;79(11):1130-5. doi: 10.1212/WNL.0b013e3182698c64. Epub 2012 Aug 29. Neurology. 2012. PMID: 22933738 Free PMC article.
-
[Additional indicators of the assessment of efficacy of disease modifying drugs (preliminary results)].Zh Nevrol Psikhiatr Im S S Korsakova. 2013;113(2 Pt 2):61-5. Zh Nevrol Psikhiatr Im S S Korsakova. 2013. PMID: 23528596 Russian.
Cited by
-
Therapeutic enquiries about biological agents as a tool to identify safety aspects and patterns of use.Eur J Hosp Pharm. 2016 May;23(3):161-165. doi: 10.1136/ejhpharm-2015-000770. Epub 2015 Oct 28. Eur J Hosp Pharm. 2016. PMID: 31156839 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
